Login to Your Account



Other News To Note


Thursday, December 23, 2010
Marshall Edwards Inc., of San Diego, will acquire isoflavone-based intellectual property from Novogen Ltd., of Sydney, Australia, for $4 million in convertible preferred stock.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription